Sascha Gutmann

4PUBLICATIONS
19CO-AUTHORS
Protein traffickingMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 03, 2025
Development of a p62 biodegrader for autophagy targeted degradation.

Zacharias Thiel, David Marcellin, Carole Manneville

|May 02, 2022
Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase Inhibitor.

Robin A Fairhurst, Pascal Furet, Patricia Imbach-Weese

|Apr 27, 2021
PAX8 and MECOM are interaction partners driving ovarian cancer.

Melusine Bleu, Fanny Mermet-Meillon, Verena Apfel

|Feb 22, 2020
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase.

Daniela Angst, François Gessier, Philipp Janser

Pageof 1